AIDS activists take over the opening of the ADIS Conference in Paris (Julay, 2017) to honor and remember prudence Mabele and demand a asswwmbled address the crisis of too many deaths among those already on Arvs. Demand access to new Arvs,  drugs made by researchers and Big Pharma at the conference for all.

According to Global Health Policy, donor government disbursements for HIV fell for the second year in a row, dropping from US$7.5 billion in 2015 to US$7.0 billion in 2016 (a $511 million or 7% decline), in current USD, bringing disbursements to their lowest level since 2010. This follows almost a decade of rapid rise, spurred on by the creation of new global HIV efforts. But increases hit up against the global economic crisis, resulting in flat funding for several years and, more recently, declines against a backdrop of constrained aid budgets.

“June is getting to a severe situation and lightens the red light”, recognized the leader of the Programa Nacional de SIDA, of Health Ministry, doctor Deisy Matos, about the shortage of antiretroviral medication happening in Venezuela, main topic during a reunion summoned by ONUSIDA, with the assistance of agents from Civil Society’s Organizations that work with AIDS.

According to Open Society Foudantions, for global health funding, the events of the past months havent´t been potentially catastrophic. But cuts this severe should worry anyone who cares about global health. By slashing AIDS funding to this degree, the United States isn’t just putting lives at risk. It’s reversing a great achievement of U.S. foreign assistance for health: providing support for socially excluded groups, and helping put them on the front lines of the fight against HIV.